RMD- ResMed Inc.
Healthcare · Medical Instruments & Supplies
Price & Performance
Performance
Analysis & Verdict
Analyst Ratings
BuyWall Street consensus from 16 analysts
12-Month Price Target
$246.44
Based on analyst estimates; price targets are opinions, not guarantees.
Fair Value Estimates
Current price: $222.99
Graham Number
√(22.5 × EPS × Book Value)
$103.51
Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.
Bazin Ceiling Price
Avg. Annual DPS (5Y) ÷ 6%
$31.53
Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.
These are simplified estimates. Not financial advice.
Buy & Hold Checklist
Quality criteria for long-term holding
9/10
90% score
Pays dividends
14Y hist.14+ years of dividend history
Dividend consistency (5Y+)
14 yrsUninterrupted dividend payments for at least 5 years
ROE above 10%
24.3%Return on equity - measures how efficiently capital is used
Positive profit margin
26.9%Net profit margin must be positive - company earns more than it spends
Revenue growth (annual)
+8.6%Annual revenue must be growing compared to the prior year
Earnings growth (annual)
+2.4%Annual earnings must be growing compared to the prior year
Debt/Equity below 2×
12.54×Low financial leverage reduces risk of distress
Current ratio above 1
3.10×Short-term assets must cover short-term liabilities
Daily liquidity above $5M
$331M/dayHigh trading volume ensures easy entry and exit
Dividend yield above 0%
1.21%Stock must distribute income to shareholders
Financials
Revenue & Results
Key Statistics
Earnings
Next Earnings
Oct 29, 2026
44
days
EPS (TTM)
$10.43
P/E (TTM)
21.4
Fwd P/E
16.9
SEC Filings & Reported Financials
Earnings History
SEC EDGAR · official filings
SEC Filings
Official EDGAR documents
Insider Transactions
SEC Form 4 · officers, directors & 10% owners
Dividends & Income
Dividends
Current DY
1.21%
5Y Avg Annual
$1.9400
Last Payment
$0.6600
Ex-Date
08/20/2026
Annual dividends paid per share
| Ex-Date | Payment | Amount | Est. DY |
|---|---|---|---|
Latest08/20/2026 | 09/24/2026 | $0.6600 | 1.18% |
05/14/2026 | 06/18/2026 | $0.6000 | 1.08% |
02/12/2026 | 03/19/2026 | $0.6000 | 1.08% |
11/13/2025 | 12/18/2025 | $0.6000 | 1.08% |
08/14/2025 | 09/18/2025 | $0.6000 | 1.08% |
05/08/2025 | 06/12/2025 | $0.5300 | 0.95% |
02/13/2025 | 03/20/2025 | $0.5300 | 0.95% |
11/07/2024 | 12/12/2024 | $0.5300 | 0.95% |
Magic Number
Shares needed to self-fund your next purchase
$222.99
Price
$0.6600
Last div. (quarterly)
338
shares
Own 338 RMD shares ($75,370.62) and each quarterly dividend pays for 1 new share - the snowball runs on its own.
Investment target
$75,370.62
New shares / year
+4 shares
Dividend Calculator
1.18% yieldEstimate RMD dividend income at the current rate.
Per year
$118.39
Per month
$9.87
≈ 44.8 shares at $2.64/share a year. Estimate only - dividends can be cut or raised.
Tools & Simulators
RMD vs Peers, Indexes & Commodities
?Click a card below to plot it on the chart
Loading history…
Parameters
Final value
$426,404.61
Total invested
$130,000.00
Total interest
$296,404.61
Balance over time
Period breakdown
| Period | Balance | Invested | Interest |
|---|---|---|---|
| Start | $10,000.00 | $10,000.00 | $0.00 |
| Year 1 | $17,270.27 | $16,000.00 | $1,270.27 |
| Year 2 | $25,267.56 | $22,000.00 | $3,267.56 |
| Year 3 | $34,064.59 | $28,000.00 | $6,064.59 |
| Year 4 | $43,741.32 | $34,000.00 | $9,741.32 |
| Year 5 | $54,385.72 | $40,000.00 | $14,385.72 |
| Year 6 | $66,094.55 | $46,000.00 | $20,094.55 |
| Year 7 | $78,974.28 | $52,000.00 | $26,974.28 |
| Year 8 | $93,141.97 | $58,000.00 | $35,141.97 |
| Year 9 | $108,726.44 | $64,000.00 | $44,726.44 |
| Year 10 | $125,869.35 | $70,000.00 | $55,869.35 |
| Year 11 | $144,726.56 | $76,000.00 | $68,726.56 |
| Year 12 | $165,469.48 | $82,000.00 | $83,469.48 |
| Year 13 | $188,286.70 | $88,000.00 | $100,286.70 |
| Year 14 | $213,385.63 | $94,000.00 | $119,385.63 |
| Year 15 | $240,994.47 | $100,000.00 | $140,994.47 |
| Year 16 | $271,364.18 | $106,000.00 | $165,364.18 |
| Year 17 | $304,770.87 | $112,000.00 | $192,770.87 |
| Year 18 | $341,518.22 | $118,000.00 | $223,518.22 |
| Year 19 | $381,940.31 | $124,000.00 | $257,940.31 |
| Year 20 | $426,404.61 | $130,000.00 | $296,404.61 |
What is compound interest?
Compound interest means that the interest you earn in one period is added to your principal, so in the next period you earn interest on a larger base. This creates exponential growth: the longer your time horizon, the more dramatic the effect.
Which rate should I use?
The S&P 500 has historically returned ~10%/year before inflation over long periods - use this for an all-equity US index fund scenario. A balanced growth portfolio (stocks + bonds) is closer to 7%. High-yield savings accounts (HYSA) are currently paying around 4-5% with FDIC insurance and zero market risk. Bonds historically return ~4% annualized.
Formula used
FV = PV × (1+r)^n + PMT × ((1+r)^n − 1) / rwhere r is the monthly rate, n is the number of months, PV is the initial investment, and PMT is the monthly contribution. Annual rates are converted to monthly viar = (1 + annual%)^(1/12) − 1.
For educational purposes only. Not financial advice. Past returns do not guarantee future results.
Discussion
Sign in to join the discussionSign inLoading…
Discover
Related Assets
Healthcare
Related Articles
About ResMed Inc.
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Location
San Diego, United States
Employees
11,370
Stock Market ROI Pro
All features, zero ads- web & app
Unlock every feature, ad-free, across our website and iOS app.
ResMed Inc. (RMD) stock trades at $222.99, up 2.16% on the day. With a market capitalization of $32.17 billion, RMD is a large-cap healthcare stock. It trades at a price-to-earnings (P/E) ratio of 21.4, a forward P/E of 16.9 and earnings per share (EPS) of $10.43. Over the most recent period the company reported 9% year-over-year revenue growth and a net profit margin of 26.9%. Below you'll find RMD's full fundamentals, fair-value estimates, dividend history, earnings and our buy, hold or avoid verdict for 2026.
RMD - Frequently Asked Questions
Is ResMed Inc. (RMD) a good stock to buy in 2026?
ResMed Inc. (RMD) shows strengths such as a strong 27% net margin and a 24% return on equity, while risks include high leverage (debt/equity of 12.5). Whether RMD is a good buy in 2026 depends on your time horizon and risk tolerance - review the full bull case, bear case and fair-value estimates above. This is informational analysis, not financial advice.
What is RMD's stock price today?
ResMed Inc. (RMD) trades at $222.99, up 2.16% on the session. Prices on this page update throughout the trading day.
Does RMD pay a dividend?
Yes. ResMed Inc. pays an annual dividend of $2.64 per share, a dividend yield of 1.21%. The most recent ex-dividend date was August 20, 2026. Its payout ratio is about 23% of earnings.
Is RMD overvalued?
With a P/E ratio of 21.4×, RMD trades at a roughly market-average valuation for the healthcare sector. Its PEG ratio is 1.27. See the Fair Value Estimates section above for Graham Number and dividend-based price targets.
What is RMD's market cap?
ResMed Inc. (RMD) has a market capitalization of $32.17 billion, classifying it as a large-cap stock in the Healthcare sector.
Disclaimer: This page - including any buy/hold/avoid view, fair value or price estimate - is generated from market data for informational and educational purposes only and does not constitute financial, investment or trading advice. Data may be delayed or inaccurate. Always do your own research and consult a licensed financial advisor before making any investment decision.